Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study

Authors: Virve Korhonen, Hanna Soini, Tuula Vasankari, Jukka Ollgren, Pieter W. Smit, Petri Ruutu

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

We investigated the epidemiology and prevalence of potential risk factors of tuberculosis (TB) recurrence in a population-based registry cohort of 8084 TB cases between 1995 and 2013.

Methods

An episode of recurrent TB was defined as a case re-registered in the National Infectious Disease Register at least 360 days from the date of the initial registration. A regression model was used to estimate risk factors for recurrence in the national cohort. To describe the presence of known risk factors for recurrence, patient records of the recurrent cases were reviewed for TB diagnosis confirmation, potential factors affecting the risk of recurrence, the treatment regimens given and the outcomes of the TB episodes preceding the recurrence.

Results

TB registry data included 84 patients, for whom more than 1 TB episode had been registered. After a careful clinical review, 50 recurrent TB cases (0.6%) were identified. The overall incidence of recurrence was 113 cases per 100,000 person-years over a median follow up of 6.1 years. For the first 2 years, the incidence of recurrence was over 200/100000. In multivariate analysis of the national cohort, younger age remained an independent risk factor at all time points, and male gender and pulmonary TB at 18 years of follow-up. Among the 50 recurrent cases, 35 patients (70%) had received adequate treatment for the first episode; in 12 cases (24%) the treating physician and in two cases (4%) the patient had discontinued treatment prematurely. In one case (2%) the treatment outcome could not be assessed.

Conclusions

In Finland, the rate of recurrent TB was low despite no systematic directly observed therapy. The first 2 years after a TB episode had the highest risk for recurrence. Among the recurrent cases, the observed premature discontinuation of treatment in the first episode in nearly one fourth of the recurrent cases calls for improved training of the physicians.
Literature
1.
go back to reference World Health Organisation. Global tuberculosis report 2015. Geneva: WHO; 2015. World Health Organisation. Global tuberculosis report 2015. Geneva: WHO; 2015.
3.
go back to reference Dobler CC, Crawford ABH, Jelfs PJ, Gilbert GL, Marks GB. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J. 2009;33:160–7.CrossRefPubMed Dobler CC, Crawford ABH, Jelfs PJ, Gilbert GL, Marks GB. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J. 2009;33:160–7.CrossRefPubMed
4.
go back to reference Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med. 2004;170:1360–6.CrossRefPubMed Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med. 2004;170:1360–6.CrossRefPubMed
5.
go back to reference Kim L, Moonan PK, Yelk Woodruff RS, Kammerer JS, Haddad MB. Epidemiology of recurrent tuberculosis in the United States, 1993-2010. Int J Tuberc Lung Dis. 2013;17:357–60.CrossRef Kim L, Moonan PK, Yelk Woodruff RS, Kammerer JS, Haddad MB. Epidemiology of recurrent tuberculosis in the United States, 1993-2010. Int J Tuberc Lung Dis. 2013;17:357–60.CrossRef
6.
go back to reference Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171:1430–5.CrossRefPubMed Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171:1430–5.CrossRefPubMed
7.
go back to reference Jaakola S, Lyytikäinen O, Rimhanen-Finne R, Salmenlinna S, Pirhonen J, Savolainen-Kopra C, Liitsola K, Jalava J, Toropainen M, Nohynek H, Virtanen M, Löflund J-E, Kuusi M, Salminen M. Infectious diseases in Finland 2015. THL, 2016. http://urn.fi/URN:ISBN:978-952-302-710-7. Accessed 7 Aug 2017. Jaakola S, Lyytikäinen O, Rimhanen-Finne R, Salmenlinna S, Pirhonen J, Savolainen-Kopra C, Liitsola K, Jalava J, Toropainen M, Nohynek H, Virtanen M, Löflund J-E, Kuusi M, Salminen M. Infectious diseases in Finland 2015. THL, 2016. http://​urn.​fi/​URN:​ISBN:​978-952-302-710-7. Accessed 7 Aug 2017.
8.
go back to reference Raisanen PE, Soini H, Vasankari T, Smit PW, Nuorti JP, Ollgren J, et al. Tuberculosis in immigrants in Finland, 1995-2013. Epidemiol Infect. 2016;144:425–33.CrossRefPubMed Raisanen PE, Soini H, Vasankari T, Smit PW, Nuorti JP, Ollgren J, et al. Tuberculosis in immigrants in Finland, 1995-2013. Epidemiol Infect. 2016;144:425–33.CrossRefPubMed
10.
go back to reference Korhonen V, Smit P, Haanperä M, Casali N, Ruutu P, Vasankari T, et al. Whole genome analysis of mycobacterium tuberculosis isolates from recurrent episodes of tuberculosis, Finland, 1995-2013. Clin Microbiol Infect. 2016;22:549–54.CrossRefPubMed Korhonen V, Smit P, Haanperä M, Casali N, Ruutu P, Vasankari T, et al. Whole genome analysis of mycobacterium tuberculosis isolates from recurrent episodes of tuberculosis, Finland, 1995-2013. Clin Microbiol Infect. 2016;22:549–54.CrossRefPubMed
12.
go back to reference Vasankari T, Kokki M, Holmstrom P, Liippo K, Sarna S, Ruutu P. Surveillance report: great diversity of tuberculosis treatment in Finland. Euro Surveill. 2007;12:17–21.CrossRef Vasankari T, Kokki M, Holmstrom P, Liippo K, Sarna S, Ruutu P. Surveillance report: great diversity of tuberculosis treatment in Finland. Euro Surveill. 2007;12:17–21.CrossRef
13.
go back to reference Lääkintöhallitus. Tuberkuloosi ja sen lääkehoito. Finnish National Board of Health. Tuberculosis and its treatment. Kapseli 15. Lääkintöhallituksen julkaisu 1985. [In Finnish]. Helsinki: Finnish National Board of Health; 1985. Lääkintöhallitus. Tuberkuloosi ja sen lääkehoito. Finnish National Board of Health. Tuberculosis and its treatment. Kapseli 15. Lääkintöhallituksen julkaisu 1985. [In Finnish]. Helsinki: Finnish National Board of Health; 1985.
14.
go back to reference Andersen PK, Perme MP. Pseudo-observations in survival analysis. Stat Methods Med Res. 2010;19:71–99.CrossRefPubMed Andersen PK, Perme MP. Pseudo-observations in survival analysis. Stat Methods Med Res. 2010;19:71–99.CrossRefPubMed
15.
go back to reference Parner ET, Andersen PK. Regression analysis of censored data using pseudo-observations. Stata J. 2010;10:408–22. Parner ET, Andersen PK. Regression analysis of censored data using pseudo-observations. Stata J. 2010;10:408–22.
16.
go back to reference Crofts JP, Andrews NJ, Barker RD, Delpech V, Abubakar I. Risk factors for recurrent tuberculosis in England and Wales, 1998-2005. Thorax. 2010;65:310–4.CrossRefPubMed Crofts JP, Andrews NJ, Barker RD, Delpech V, Abubakar I. Risk factors for recurrent tuberculosis in England and Wales, 1998-2005. Thorax. 2010;65:310–4.CrossRefPubMed
17.
go back to reference Kokki M, Holmstrom P, Ruutu P. High sensitivity for tuberculosis in a national integrated surveillance system in Finland. Euro Surveill. 2005;10:90–3.CrossRefPubMed Kokki M, Holmstrom P, Ruutu P. High sensitivity for tuberculosis in a national integrated surveillance system in Finland. Euro Surveill. 2005;10:90–3.CrossRefPubMed
18.
go back to reference Bang D, Andersen AB, Thomsen VO, Lillebaek T. Recurrent tuberculosis in Denmark: relapse vs. re-infection. Int J Tuberc Lung Dis. 2010;14:447–53.PubMed Bang D, Andersen AB, Thomsen VO, Lillebaek T. Recurrent tuberculosis in Denmark: relapse vs. re-infection. Int J Tuberc Lung Dis. 2010;14:447–53.PubMed
20.
go back to reference Selassie AW, Pozsik C, Wilson D, Ferguson PL. Why pulmonary tuberculosis recurs: a population-based epidemiological study. Ann Epidemiol. 2005;15:519–25.CrossRefPubMed Selassie AW, Pozsik C, Wilson D, Ferguson PL. Why pulmonary tuberculosis recurs: a population-based epidemiological study. Ann Epidemiol. 2005;15:519–25.CrossRefPubMed
21.
22.
go back to reference Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007;11:828–37.PubMed Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007;11:828–37.PubMed
23.
go back to reference Kim L, Moonan PK, Heilig CM, Woodruff RSY, Kammerer JS, Haddad MB. Factors associated with recurrent tuberculosis more than 12 months after treatment completion. Int J Tuberc Lung Dis. 2016;20:49–56.CrossRefPubMedPubMedCentral Kim L, Moonan PK, Heilig CM, Woodruff RSY, Kammerer JS, Haddad MB. Factors associated with recurrent tuberculosis more than 12 months after treatment completion. Int J Tuberc Lung Dis. 2016;20:49–56.CrossRefPubMedPubMedCentral
24.
go back to reference Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, et al. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. 2011;15:906–11.CrossRefPubMedPubMedCentral Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, et al. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. 2011;15:906–11.CrossRefPubMedPubMedCentral
25.
go back to reference Millet J-P, Orcau A, de Olalla PG, Casals M, Rius C, Cayla JA. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health. 2009;63:799–804.CrossRefPubMed Millet J-P, Orcau A, de Olalla PG, Casals M, Rius C, Cayla JA. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health. 2009;63:799–804.CrossRefPubMed
26.
go back to reference El Sahly HM, Wright JA, Soini H, Bui TT, Williams-Bouyer N, Escalante P, et al. Recurrent tuberculosis in Houston, Texas: a population-based study. Int J Tuberc Lung Dis. 2004;8:333–40.PubMed El Sahly HM, Wright JA, Soini H, Bui TT, Williams-Bouyer N, Escalante P, et al. Recurrent tuberculosis in Houston, Texas: a population-based study. Int J Tuberc Lung Dis. 2004;8:333–40.PubMed
Metadata
Title
Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study
Authors
Virve Korhonen
Hanna Soini
Tuula Vasankari
Jukka Ollgren
Pieter W. Smit
Petri Ruutu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2818-6

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue